SK Life Science recently issued a refund notice for an epilepsy drug following a 340B price ceiling recalculation. The New [...] …
Articles by : Bella Czajkowski, National Correspondent
Johnson & Johnson (J&J) added Ustekinumab, the unbranded version of psoriatic arthritis treatment Stelara, to its 340B contract pharmacy restrictions [...] …
A shuttered Philadelphia-area hospital recently amended its legal filing in a class action case against CVS Health’s (CVS) contract pharmacy [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Virginia Gov. Glenn Youngkin (R) signed a bill this week that will expand the state’s existing 340B pharmacy benefit manager [...] …
Drugmakers Merck and Novartis recently updated their 340B contract pharmacy restrictions, modifying what states are exempt from such policies following [...] …
The Trump administration this week continued to oppose drug industry attempts to unilaterally convert 340B discounts to a rebate model, [...] …
Mehmet Oz, President Donald Trump’s (R) nominee to lead the Centers for Medicare & Medicaid Services (CMS), faced persistent questioning—primarily [...] …
Two drugmakers recently notified covered entities of adjustments to their 340B drug ceiling prices and resulting refund eligibility. Sumitomo Pharma [...] …
A federal judge ruled that healthcare conglomerate CVS Health did not violate antitrust laws with its contract pharmacy policies, dismissing [...] …